Stay updated on Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.

Latest updates to the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page
- Check3 days agoChange DetectedAdded a MedlinePlus Genetics topic on Type 2 diabetes and bumped the page revision to v3.0.2; removed the 'Back to Top' link (minor UI change).SummaryDifference0.5%
- Check11 days agoChange DetectedThe page has been updated to version 3.0.1, and the topic of Type 2 diabetes related to MedlinePlus Genetics has been removed.SummaryDifference0.5%
- Check18 days agoChange DetectedThe web page has undergone significant updates, including the addition of new drug information related to Dapagliflozin and Saxagliptin, as well as related topics on diabetes prevention. However, several previous drug categories and information have been removed, indicating a shift in focus.SummaryDifference4%
- Check25 days agoNo Change Detected
- Check32 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check39 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11, indicating a revision in the content.SummaryDifference0.1%
- Check47 days agoChange DetectedThe web page has been updated to version 2.16.10, and a previous service alert regarding planned maintenance has been removed.SummaryDifference1%
Stay in the know with updates to Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin Safety & Efficacy in Asian T2DM Clinical Trial page.